“炒股”收益大减，两面针净利骤降

Core Viewpoint - The company, Two-Phase Needle, forecasts a significant decline in net profit for the year 2025, projecting a decrease of 87.67% to 93.83% compared to the previous year, primarily due to losses in trading financial assets and reduced investment income [1][4][6]. Financial Performance - The company expects a net profit attributable to shareholders of between 5 million to 10 million yuan for 2025, a decrease of 71.1 million to 76.1 million yuan from the previous year [1][4]. - The forecasted non-recurring net profit is estimated to be between 1 million to 6 million yuan, reflecting a decline of 294.73 thousand to 794.73 thousand yuan year-on-year [4]. - In the previous year, the company reported a total profit of 110.45 million yuan and a net profit of 81.1 million yuan [4]. Business Overview - Two-Phase Needle, known as the "first stock of toothpaste," was established in 1941 and became the first self-branded listed company in the A-share toothpaste industry in 2004 [5]. - The company specializes in the research, production, and sales of daily chemical products, with its main products including Two-Phase Needle toothpaste, Mulanze, Xiaoyao, and Fangcao [5]. Recent Developments - On January 16, the company announced a board of directors' election, with the eighth board's term having expired [7]. - The company is focusing on improving operational performance by enhancing governance structures and optimizing product offerings to increase market competitiveness [8].